SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " money " 2,463 found 🔀 AI-powered Shuffle
MLB Expert Picks & Baseball Predictions for August 14
MLB expert picks and moneyline, run line, and Over/Under predictions for Friday, Aug. 14, featuring the Dodgers, Cubs, and Rangers.
Opinion: After Michigan, Will Pro-Israel Politics Get a Ground Game?
Michigan’s $80 million Democratic U.S. Senate primary demonstrated that money can buy attention, but it cannot create a movement.
Opinion: After Michigan, Will Pro-Israel Politics Get a Ground Game?
Michigan’s $80 million Democratic U.S. Senate primary demonstrated that money can buy attention, but it cannot create a movement.
‘Call Her Daddy’ host Alex Cooper’s Unwell beverage business is shutting down
On Wednesday, Unwell raised money from Hollywood super agent Patrick Whitesell that valued the entire business at $500 million. It will go somewhere else.
Lawrence mayor faces federal charges, accused of misusing COVID business loans
Lawrence Mayor Brian DePeña was arrested Friday morning on federal charges alleging the misuse of COVID business loan money.
The hidden politics of time: How clocks, calendars — and now-contentious time zones
It flies. It heals all wounds. It can be of the essence, and it can be money. We thrill in the best of it, lament the worst. We’re warned not to waste it, since we can’t turn it back — even as we try to make up for when it’s lost.
Report Says Average Business Trip Cost Jumped From $834 to $1,128 from 2024 to 2026
Research from Engine shows employees spending 12 days a year on travel-related admin tasks
The hidden politics of time: How clocks, calendars — and now-contentious time zones
NEW YORK (AP) — It flies. It heals all wounds. It can be of the essence, and it can be money. We thrill in the best of it, lament the worst. We're warned not to waste it, since we can't turn it back — even as we try to make up for when it's lost.
The hidden politics of time: How clocks, calendars — and now-contentious time zones
NEW YORK (AP) — It flies. It heals all wounds. It can be of the essence, and it can be money. We thrill in the best of it, lament the
The hidden politics of time: How clocks, calendars — and now-contentious time zones
NEW YORK (AP) — It flies. It heals all wounds. It can be of the essence, and it can be money. We thrill in the best of it, lament the worst. We’re warned not to waste it, since we can’t turn it back — even as we try to make up for when it’s lost. […]
Exploring how discretionary time impacts health | Harvard T.H. Chan School of Public Health
Time may be money, but is time health? That’s what doctoral candidate Laura Chen is trying to find out.
AI needs science’s search history
“Actually, that’s where the gold is,” said Alasdair Russell, my graduate school friend who leads a pre-clinical genome editing group at Cambridge. He was talking about the winding road of science that is omitted from published papers. “When you’re discussing how to do the experiment, and why this way is better than another way, and what does the data really mean? I know what it shows, but what does it mean?” At RAAIS 2026, he described how his group has begun logging the twisting path of discovery as it happens, recording the verbal and written exchanges that normally disappear. Ideas become nodes in a living graph: they branch when a meeting produces two plausible experiments, merge when separate lines of evidence converge, and go dark when someone quietly stops pursuing them. In his implementation, one agent scores novelty, while another tries to learn “how scientists think and how they navigate through a complex world of data,” so that high-potential nodes can trigger deeper investigation. As frontier AI labs deploy agents toward scientific discovery, giving AI authentic scientific taste remains a trillion-dollar dilemma. The bottleneck is that the record we have kept for centuries of science might be insufficient to get us there. The experiments that never make the paper Peter Medawar, 1960 Nobel laureate and “father of transplantation,” asked in 1963 whether the scientific paper was a fraud, and answered yes: the form of the paper misrepresents the thinking that produced it. Sixty years on, the diagnosis is unchanged. A paper presents a clean progression from hypothesis to result to conclusion. Lost along the way are the unconventional theories, the abandoned or unaffordable methods, and the underwhelming and inconclusive data. It reads like a browser history with every dead end deleted: the ten open tabs, the four rephrased queries, the wrong turn down a subforum. All scrubbed, leaving one clean path from question to answer as the canonical path. What has changed since then is that the discarded material is now worth something. No high-impact journal wants these artifacts, but raw trial and error is the most likely source of the training data required to develop scientific intuition, or what researchers call taste. Earlier attempts to capture the discards were motivated by scientific integrity. The Journal of Negative Results in Biomedicine launched in 2002 to publish rigorous studies that disputed established models or exposed ineffective treatments. Its archive preserved negative conclusions after they had become papers, rather than the live alternatives and arguments that produced them. BioMed Central closed it in 2017, saying the mission had been served now that other journals publish null results. A less generous reading is that in fifteen years it published around 200 papers because almost nobody wants to read a negative result, let alone write one up when it will not count toward academic tenure. AI models are different. Even an uninteresting negative result can be useful, provided it is labeled. Earlier this year, Anthropic put a version of this to the test. The company pulled 129 decision points from real Claude Code sessions between January and March 2026, showed models the work up to a human detour, and asked what should happen next. Claude Mythos Preview beat the human choice 64% of the time, while Opus 4.5 managed 51%. The comparison was tilted toward the models because Anthropic deliberately chose moments where the human decision had room for improvement. On 127 further scenarios where the human action was already strong, the models improved on it only about 20% of the time. The study was possible because Anthropic’s researchers work inside a tool that logs by default. The reasoning, detours and outcome are produced in the same working environment. Biology has no equivalent. Its reasoning happens in hallways, at benches, in Slack threads and on whiteboards, while the outcome arrives weeks later somewhere else. The record has to emerge from the work itself. Ask scientists to reconstruct it afterwards and we’ll create another polished account. Subscribe A log is not a label Before any of this becomes training data, a negative result has to say what failed. The first paper published in the Journal of Negative Results in Biomedicine examined 234 negative studies across five leading medical journals. Only 30% discussed statistical power, and half clearly defined a primary outcome. Tell a model an experiment failed, without telling it whether the assay was underpowered, a reagent had degraded, or the hypothesis was simply wrong, and it will learn noise with confidence. Decision histories have a second missing label too. When a lab considers five experiments and runs one, only the chosen branch returns an outcome. The other four are experimental counterfactuals. Researchers call this the selective labels problem: the data reveal results only for the actions someone chose to take. Such a record can teach a model to imitate a lab’s taste, but it cannot establish that the taste was good. It also smuggles local constraints into general lessons. A lab that never ran cryo-EM because it did not own a microscope teaches a model that cryo-EM is rarely the right call. Alasdair’s nodes preserve the candidate set, which is the necessary first step. To be useful, each decision record needs six fields: The evidence available at that moment, and nothing that arrived later. The candidates considered, including the ones dismissed in a sentence. For each candidate: the expected result, the confidence attached to it, and the cost in time and money. The route chosen, and the reason. What happened next. How the evidence changed the scientist’s view. These must be timestamped before the outcome, because hindsight turns uncertainty into inevitability. Disagreement also has to survive. Averaging three scientists into one clean rationale reproduces exactly the information loss we are trying to fix. But there is an obvious failure mode here. Once decisions are logged and scored, people log for the record post-facto. Anyone who has watched an electronic lab notebook fill up with retrospective tidying knows how quickly a research tool becomes a compliance exercise. A record that costs a scientist ten minutes of honest reflection per decision is worth far more than one that costs an hour of performance. A publication initiative called Registered Reports offers a useful starting point. Here, researchers submit their rationale, methods and analysis plan for peer review before the data exist, and the journal commits in principle to publish if they follow the approved plan. Nature has now expanded the format across every field it covers. This approach to paper writing timestamps intent before the outcome, but it freezes one plan. A useful search history must also preserve how the plan changed, which alternatives were rejected, when, and on what evidence. Subscribe Run the runner-up Autonomous labs show what happens when decisions and outcomes are connected in a loop. Liverpool’s mobile robotic chemist ran 688 experiments over eight days in a ten-variable formulation space. A batched Bayesian search used each result to choose the next experiments and found photocatalyst mixtures six times more active than the starting formulations. Every completed experiment changed what the system did next. The robot optimized within a goal and search space that humans had already chosen. It did not decide which scientific question mattered. So what this work demonstrates is narrower, but still useful: a search history pays off when the options return standardized outcomes quickly. Open-ended biology is harder because branches can take weeks and the discarded alternatives may never be run. Some exploration therefore has to be bought. Where two branches are plausible and the stakes justify the cost, a lab should sometimes run the runner-up. Otherwise the record captures what today’s scientists usually chose and stays silent on what they systematically overlooked. A funder could ring-fence a small fraction of a grant for the branch not taken, provided that the decision record and the outcome are both deposited. That costs money, but so does having every lab rediscover the same abandoned path. Test whether taste transfers When it comes time to evaluate if our new AI system exhibits taste, the comparison should run across laboratories and fields. At selected decision points in a live research campaign, we should freeze the six fields: the evidence, the candidates, expected results, confidence, costs and the choice made. Experts then rank the options before the outcomes are known, and those outcomes are checked independently later. We could give models one of two diets - papers alone, or papers plus decision histories - and ask them to rank the next experiment on unfamiliar projects. Then, we score information gained per dollar and week, calibration, and how quickly weak branches are abandoned. If histories improve choices only inside the lab that produced them, they amount to useful organizational memory. If they improve choices on unfamiliar problems elsewhere, Alasdair’s group will have captured something science has never managed to write down: a transferable record of taste. Until that happens, a scientific search history is a promising record, not yet a training set.
Professor’s Alleged Role in China Programs Leads to Ban From US Funding
Tao Li failed to disclose participation in Chinese talent plans while helping to award US research money, probe concludes.
Treasury changes rules for businesses reporting ownership
The Biden-era regulation was intended to prevent money laundering, but critics said it was overly onerous.
How money actually works in American elections
The midterms are flooded with cash, but donors don’t always get what they want. A political scientist explains where the money matters most.
Florida’s appointed attorney general rakes in more campaign cash
The money into the attorney general’s campaign account included $2,670 from the state’s public financing program.
Money and politics play a role in public education curriculum gaining popularity in Texas
As Texas lawmakers put more restrictions on what is approved for the classroom, one expert told ABC13 that one curriculum has a clear advantage.
In Senate race, Flanagan and Tafoya bring vastly different politics, experience
Democrat Lt. Gov. Peggy Flanagan and Republican Michele Tafoya have come to politics from very different routes and backgrounds. As the two battle it out for an open U.S. Senate seat, analysts expect a large amount of money to flow into the race.
5 PE Companies to Watch in 2026 and Beyond
This is an exclusive BHB+ article. It's been a turbulent year for behavioral health and investors value certainty. While deals are still crossing the
OPB’s First Look: Corporate money in Oregon politics
A new legal theory to skirt Citizens United could be tested in Oregon. Here's your First Look at Wednesday's news.
NFL top 5 richest teams in 2026 according to Sportico
This proves that being worth a lot of money doesn't mean your football team wins games.
Ramp: Anthropic's Fable 5 lagged behind OpenAI's GPT-5.6 Sol in July
Although OpenAI trails Anthropic in business adoption, it won a moneymaking battle in July with its most advanced model, GPT-5.6 Sol.
Rural health panel divvies $205M in federal funds for Wyoming healthcare
Panel assigned money to hospitals, EMS services and maternal care in attempt to shore up medical access.
We asked Madison: How much money do you make?
Over a dozen states have pay transparency laws, including Illinois, Minnesota, New York and Washington. While no such laws exist in Wisconsin, money is still at the top of mind
Treasury ends ownership reporting rules for U.S. companies
The rules, intended to combat money laundering and other financial crimes, imposed an undue burden on American businesses, Treasury Secretary Scott Bessent said.
Cramer's lightning round: Buy Hinge Health
"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
2 men used counterfeit money at Bucks County businesses, police say
The duo used fake money at an Arby's and Taco Bell, and police said they believe other businesses in the Feasterville area were targeted.
Alphabet's AI Story No Longer Runs Through The Business That Funds Everything Else
The advertising line management once pointed to for AI money has been speeding up, not slowing down.
AI Could Help Researchers Get Funding—But at What Cost?
Scientists who use AI to draft research proposals are earning more money, but their ideas may be less likely to move the field forward.
The Guardian view on AI money in US politics: not the way to hold an urgent democratic debate
Editorial: Amid public concern over the impact of new technology, Silicon Valley’s use of its wealth to influence specific election races is an unwelcome development
Will Andy Burnham’s everyday fixes be enough to get the public on his side?
The prime minister’s money-saving policies are popular but they are yet to convince voters he can take on the big things
How one of Southern California's biggest entertainment hubs has become a battleground over big-money billboards
How one of Southern California's biggest entertainment hubs has become a battleground over big-money billboards
One of Southern California's biggest entertainment hubs has become a battleground over big-money bil
Yankees receive $2.6 billion in deal with private equity fund
The Yankees may use the money to handle debt and pursue new ventures.
The US tried to stop cartel money-laundering. It devastated mom-and-pop businesses instead
Small businesses pay hidden toll after money-transfer rule change to curb illicit activities near the US-Mexico border
The U.S. Healthcare System is Already Mostly Socialized
Now that Abdul El-Sayed is the Democratic nominee for Michigan’s open Senate seat, the outcome of this crucial race will depend mainly on two things: Whether Republicans succeed in demonizing El-Sayed because he’s brown and a Muslim, and whether they succeed in demonizing him as a left-wing radical. I will defer for the now the question of whether bigotry will be effective this year, although I will address it another day. What I want to address instead is El-Sayed’s signature issue — healthcare. Yes, El-Sayed advocates Medicare for All, a position the usual suspects denounce as “socialism.” I will get to the politics of his stance soon. Today, however, I want to talk about the substance. We should be clear that El-Sayed doesn’t even call himself a socialist. On the contrary, he explicitly disavows the label, saying “I’m a capitalist who just knows about capitalism”. In fact, as I explained in a previous post, the policies that El-Sayed advocates qualify him as a social democrat, not a socialist. Still, El-Sayed advocates a system under which the government would pay almost all medical expenses. Isn’t that socialism? Well, if that is the criterion then much of U.S. healthcare is already socialist. In fact, the government’s role is so large that U.S. healthcare is better described as partially privatized socialism than as anything resembling a free market. Let’s start with the raw numbers on health insurance, which pays the bulk of Americans’ medical expenses. Americans receive health insurance either from private companies or from public programs, overwhelmingly Medicare and Medicaid. Here’s what the breakdown of coverage and spending between private and public looked like in 2024: While a majority of Americans with health insurance get it from private companies, well over 100 million of us are covered by government programs instead. And these government programs pay more total dollars for medical bills than the private insurers do. Why do government programs that cover a minority of the population account for a majority of health insurers’ outlays? Mainly because Medicare covers seniors, and we’re expensive. Also, while Medicaid covers many younger Americans, disabled and elderly beneficiaries account for most of its spending. Even by the raw numbers, then, U.S. health insurance looks as much public as private. But that understates the government’s role: Private health insurance in the U.S. is both highly regulated and heavily subsidized. This is obviously true for the insurance coverage purchased by tens of millions of Americans through the exchanges established by the Affordable Care Act. But employment-based health insurance, which covers 161 million Americans, is far more of a government creation than most people realize. For employment-based insurance exists largely because of huge implicit government subsidies that come with major strings attached. Here’s how that works. If your employer pays you $10,000, that’s taxable income. But if your employer pays $10,000 toward a company health insurance plan that meets certain criteria, it isn’t taxable. That’s a huge effective subsidy, running at more than $300 billion a year. Take that subsidy into account, along with the more than $100 billion per year spent subsidizing policies purchased under the ACA, as well as the outlays on Medicare and Medicaid, and net effect is that the government pays for more than two-thirds of Americans’ health insurance. Granted, there are strings attached. Roughly speaking, employment-based health plans can’t discriminate based on medical history — that is, they can’t deny coverage to employees with pre-existing conditions — and they also can’t offer the plans only to highly compensated employees — a health plan that is only for the C-suite is considered taxable income. So given the restrictions of the federal tax code, employer-based health insurance is a lot like Obamacare, which also prohibits discrimination based on medical history and provides subsidies to make insurance affordable to lower-paid workers. The fact is that virtually all of private healthcare insurance is already well under some form of government control through regulation and tax subsidies. How should we think about this system? First of all, is Medicare socialist? Don’t tell anyone, but the way Medicare operates — it covers every senior’s medical expenses, whatever they turn out to be, while being funded by taxes that depend on one’s income — could be summarized by the old Marxist slogan “From each according to his ability, to each according to his need.” And back in 1961, when Ronald Reagan was the face of a last-ditch effort by the American Medical Association to block the creation of Medicare, he denounced Medicare as “socialized medicine” and warned that it would destroy our freedom. In reality, American freedom survived until Jan. 20, 2025, while Medicare is immensely popular, with an 82 percent favorable rating in the most recent KFF survey. Medicaid, government health insurance for lower-income Americans, comes in at 73 percent. This is in sharp contrast to public views about private insurers, who are widely disliked if not hated and accused of denying essential care. Furthermore, if Medicare is socialism, then the whole U.S. health insurance system, with the government paying most of the bills and placing conditions on private insurers, is almost equally socialist. If you insist on calling any program the government pays for and regulates socialist, then U.S. healthcare would best be described as a partially privatized form of socialism. And one must ask, what is the point of the part that is privatized? Do private insurers add anything positive? Or are they simply parasites, skimming off money that could have been paying for care? The case for viewing insurers as parasites is strong. Many Medicare benefits are now delivered via Medicare Advantage, that is, plans paid for by the government but run through insurance companies. MedPAC, an independent advisory commission, estimates that last year Medicare Advantage plans were overpaid by $84 billion, thanks to practices such as “upcoding,” in which patients’ health problems are overstated to get larger sums from Medicare. Assessing the waste from employer-based insurance is harder, but most evidence suggests that private insurers have substantially higher administrative costs than Medicare does. Furthermore, the complexity of private insurance, with multiple payers all trying to deny care when they can, is a huge burden both on providers — doctors, nurses, and hospitals — and on patients. What do private insurers offer to compensate for these costs? One must go through intellectual contortions to avoid the conclusion that they are, in fact, parasites. Which brings me back to El-Sayed. In supporting Medicare for All, he’s basically calling for an end to the partial, parasitic privatization of a healthcare system that is already hugely dependent on public funding. When one looks at it that way, it’s not at all a radical proposal. Admittedly, the political lift requires overcoming the opposition to higher taxes to pay for Medicare for All. Political realism rather than economics was the reason I and many other progressives supported Obamacare, with all its complexities, rather than demanding an immediate move to Medicare for All. But the political calculus may very well have shifted since the 2000s, as Americans are fed up with a system of unaffordable premiums, rampant claim denials, and byzantine claim administration. Moreover, funding healthcare insurance through taxation would allow for a much more progressive distribution of the cost. That is, compared to the present system, middle-income households would pay less as high-income households would pay more. And the U.S. would stop wasting large sums on pointless administrative costs. So let’s be clear: El-Sayed’s healthcare platform is perfectly reasonable on the merits of cost, fairness and health efficacy. And with private insurers never more hated, while millions of Americans are losing their health insurance, 2026 may be its time. MUSICAL CODA
Corporate Leaders Have Moved Left, But the Money Hasn’t Followed
In new research, Reilly S. Steel finds that corporate leaders’ individual political preferences are shifting left, but their aggregate spending remains skewed to the right.
A ballot fight over corporate money in Michigan politics is coming to voters
Voters will decide whether to upend campaign finance in Michigan when they head to the polls in November as outrage over money in politics intensifies pressure for reform.
A Fake Email Redirected $113,050 Into His Business Account, Then Nearly All the Money Was Gone in Hours
A North Dakota man is facing federal fraud charges after prosecutors say a nearly identical email address redirected $113,050 owed to an art dealer into ... Read More
Rock, Reggae & Relief benefits Café Momentum in downtown Pittsburgh
Rock, Reggae & Relief filled Downtown with daytime music and dancing while raising money for Café Momentum Pittsburgh and its youth-training programs.
Defunding America’s ‘best idea’
Trump administration policies have left many national parks short on staff and money.
How much money is a 24-team College Football Playoff worth? A key answer is coming this fall
The Big Ten wants 24 teams. The SEC has questions. Fox wants in, and ESPN wants things to stay small. Here's how the money could decide the next Playoff format.
A pilot couple explains how they make money buying and renting RVs
Full-time pilots Carrie and Brian Smiths learned early on that owning an RV fleet would not be "a cakewalk."
Media Buying Briefing: How Instrument won Croc’s business in a day
The agency’s calling card is applying tech-driven creative for clients to get them to think far beyond what they're comfortable with.
Political analysts give last-minute take on Minnesota primaries: "Money matters"
Inside a meme factory: meet one of thousands of Indonesians trading political outrage clicks for Facebook cash
Exclusive: Adira says she doesn’t know much about her target countries or even know who their leaders are. Instead she’s chasing money from Meta, which pays for engagement
'Harry Potter' star Jessie Cave says joining OnlyFans 'saved' her life
Jessie Cave has revealed she has already made more money on OnlyFans than she did in her nearly two-decade career as an actress, which includes several "Harry Potter" movies.
MLB Predictions and Moneyline Picks for Sunday, August 9
We share MLB moneyline predictions for all 15 games on Sunday's slate, highlighted by the Houston Astros beating the San Diego Padres as +113 underdogs!
Community raises money to help Detroit activist Minister Malik Shabazz with medical bills
Auto loan refinancing: How it works and when it could save you money
Explore how auto loan refinancing works, when it makes financial sense, and how preapproval options can help lower your monthly car payments.
‘Harry Potter’ star reveals how much money she’s made from OnlyFans
‘Harry Potter’ actress Jessie Cave shared a staggering milestone about how much she’s earned in her 1.5 years on OnlyFans: ‘It’s genuinely saved our lives.’
Can would-be buyer afford to take over more Chicago-area hospitals?
Insight Health Systems is in talks to take over West Suburban Medical Center and Weiss Memorial Hospital, which closed in the last year. But records show its Chicago hospital has money troubles.
Missouri's sports betting tax revenue decreased in June despite FIFA World Cup in Kansas City
The total amount wagered in June was $258.3 million, a 0.8% increase from May. Almost all sports bets were made on mobile betting sites, accounting for 99.5% of all money wagered.
Scientists create OnlyFans account for marmots to fund research
UCLA professor Daniel Blumstein and his team started an OnlyFans account to raise money for their research amid government funding cuts
Inside the Zay Flowers deal
Earlier this week, the Ravens and receiver Zay Flowers agreed to terms on a new deal that, by way of new money, put him in the Justin Jefferson tax bracket at $35 million annually.
A pardoned Capitol riot defendant wants her restitution money back. The Justice Department wants to keep it
After the protracted demise of the $1.776 billion fund meant to pay perceived victims of government lawfare, prosecutors say they don’t have to give a now-pardoned January 6, 2021, defendant her restitution money back.
Google's $1,300 Pixel 11 Pro XL will need one aggressive move to justify its price
More money should buy more than AI
Rural behavioral health in New Mexico: why the money doesn't become care
A nonprofit healthcare CEO says New Mexico has plenty of money but needs to approach delivering services in rural areas differently.
Downtown New Orleans taxes itself an extra $10 million a year. Here's where the money goes.
Check in with the chief of the Downtown Development District after one year on the job.
Lofgren, Whitesides Demand Transparency on OSTP Initiative Funded with NSF Money
The House Committee on Science, Space and Technology
Dr. Abdul El-Sayed on Historic Michigan Win: “People Are Sick and Tired of This Politics of Hatred”
We speak with Dr. Abdul El-Sayed after his victory in Michigan’s primary race for U.S. Senate sent shockwaves through the Democratic Party. El-Sayed, a former public health official, ran a progressive campaign focused on affordability, Medicare for All, getting money out of politics, and opposing Israel’s genocide in Gaza. He defeated Congressmember Haley Stevens, who was backed by tens of millions in outside spending including by AIPAC, the powerful pro-Israel lobby group. “In an era where many of us can’t afford basic things like groceries or rent or healthcare, the idea that your government is sending your tax dollars to buy bombs and tanks for foreign governments seems anathema,” El-Sayed says. “That money could be spent to fix your potholes, rebuild your kid’s school.” El-Sayed says his focus now is on beating Republican nominee Mike Rogers, whom he calls a “bootlicker for Trumpism,” and to present a positive vision for his party that can lead into the next Democratic presidential administration.
Budget Battle Erupts in Nation’s Capital Over Opioid Settlement Money
Washington, D.C.’s 2027 fiscal-year blueprint reflects a debate playing out around the U.S.: whether opioid settlement money should be used to free up taxpayer dollars by paying for existing responsibilities instead of new programs.
Court orders Instagram and Facebook's Meta to pay $567M to address kids' mental health online
Judge Bryan Biedscheid said in a ruling late Thursday that the bulk of the money will be used for treatment services for young people.
Michigan Supreme Court is asked to block money-out-of-politics question
A business-backed group is asking the Michigan Supreme Court to invalidate a campaign finance petition over a dispute about signature certification.
Money, politics, and the ‘beautiful game’: FIFA battles to win back trust
Dissent has kicked off over the future of the soccer World Cup, leading to calls for a change at FIFA.
Bennett calls on Pingree, Charles to disclose donors
Maine State Senator and independent candidate for governor Rick Bennett is demanding more transparency in campaign finance, asking opponents Democrat Hannah Pingree and Republicam Bobby Charles to disclose the names of who he said are anonymous donors funding their campaigns.
Most Division I colleges lose money on sports
Over 90 percent of these athletic programs spend more money than they generate, according to the Government Accountability Office.
US Stand Up for Science movement expands to Europe
A grassroots movement by scientists in the US pushing back against threats to academic freedom is setting up a Swiss outpost to take the movement global. Stand Up for Science started in February 2025 to protest against politically-motivated grant cancellations by the Trump administration. Since then, it has organised numerous rallies by scientists and turned into a broader campaigning organisation, supporting “pro-science” political candidates and attempting to impeach Robert F. Kennedy Jr, the health and human services secretary the group accuses of advancing “quack” science. Now, Stand Up for Science is establishing a Swiss office to take some of its campaigning beyond the US, and its leader is urging European academics to organise similar pro-science groups in case they face similar threats in Europe. There will likely be “spillover” to Europe from what the Trump administration is attempting in the US, said Colette Delawalla, chief executive of Stand Up for Science, who last month returned from a tour of Europe. “Are we going to see a Trump-style scientific [. . .] take over in the same way?” she asked.Delawalla, who is doing a PhD in clinical psychology, said she was driven to help found the organisation after the Trump administration started cancelling health research grants in politically taboo topics, such as transgender people, diversity and HIV, in early 2025. Since then, the administration has introduced several other measures that infringe academic and institutional autonomy.It threatened to cut Harvard University’s federal funding unless the university accepted a “critical mass” of new faculty and students to create “viewpoint diversity.” And this year, it proposed explosive new rules that would allow political appointees at research funders to screen grants to make sure they “advance the president's policy priorities.”US scientists have been at times stunned by the volume of announcements, and the country’s researchers were relatively unprepared. “We sit in front of the fire hose every day,” said Delawalla. For this reason, European scientists need to prepare now for similar assaults. “If you've got a little bit of extra time to start thinking through, and making those preparations and building community and solidarity,” then European researchers will “start five steps ahead of where we were.” She plans to return to Paris in September to share experiences with concerned French academics. Is Le Pen the same?During her European tour, Delawalla said that French academics were beginning to worry about a National Rally (RN) victory in presidential elections next year. She said there were “chilling similarities” between Trump and Marine Le Pen, the RN’s likely candidate. However, so far, the RN hasn’t proposed anything nearly as radical as the Trump administration has carried out. Its current manifesto is all but silent on university and research policy. Le Pen’s 2022 manifesto bemoaned a lack of French R&D spending, including in fundamental research, and promised to modernise labs and strip away grant bureaucracy. The party’s 2024 European election manifesto explicitly supported the Erasmus+ student exchange programme, scientific exchange and joint European technology projects. However, a Le Pen victory next year could see France drastically cut its contribution to the EU, which would hit the budget for science and innovation. Meanwhile, more restrictive immigration policies could hit university recruitment of faculty and students. Climate science denial?As heatwaves and wildfires have ravaged France, the RN has sought to distance itself from previous comments casting doubt on climate science.In the UK, the radical-right party Reform UK, now second in the polls, denied climate research in a draft of its 2024 election manifesto, but its leader, Nigel Farage, then appeared to quietly U-turn and said he was “not arguing the science.” By contrast, Trump has repeatedly and explicitly denied climate change science, in 2025 calling it “the greatest con job.” Like the RN, Reform UK has been light on research and university policy. However, it did say in its 2024 manifesto that universities should suffer “heavy financial penalties” for allowing “political bias or cancel culture” on campus, building on laws brought in by a previous Conservative government. Ahead of September state elections in Saxony-Anhalt in Germany, the poll-leading Alternative for Germany has proposed abolishing gender studies and postcolonial studies, and promised money for “critical” climate research and studies of Islam. Starts with rhetoricEven if European radical right parties aren’t currently planning the draconian policy measures of the Trump administration, Delawalla said that academics should not be complacent, and fight even small funding restrictions or anti-science talk from the start. “It starts off with sowing distrust about institutions,” she said. “It starts off with these small things, and then all of a sudden it's there.” There are other, more established science and university advocacy groups in the US aside from Stand Up for Science. But the group stands out because of Delawalla’s refusal to attempt to appear politically bipartisan or conciliatory. “I firmly believe that the US is experiencing fascism,” she said. “We’re not trying to win over the super Maga people,” she said, “and we never have been.” The lesson of the US is that even if universities or other institutions capitulate to government demands, this doesn’t save them from cuts and restrictions. “It doesn’t matter what people do,” she said. Global “pseudoscience”Another aim of Stand Up for Science’s push into Europe is to better coordinate a campaign to protect people in poorer countries from what the group describes as “pseudoscientific exploitation,” trials outside the US used to build a case against things like vaccines. Earlier this year, the group sent an investigator to Guinea-Bissau to investigate a controversial, Danish-run Hepatitis B vaccine project funded by the US Centers for Disease Control and Prevention.The study would have withheld a proven vaccine from newborns, Stand Up for Science argued in a briefing it presented to Congress, risking their health. Significantly, the research group based in Guinea-Bissau, known as Bandim, focuses on the “non-specific effects” of vaccines: impacts on health beyond preventing the target disease. Related articlesEuropean researchers sound the alarm that Trump rule changes will hit cooperationData corner: which fields of health science is the US curbing? The US ‘golden age’ science strategy: what Europeans need to know The suspicion is that the study was funded as part of an attempt to shop around for results that could help build a case against vaccines in the US, said Delawalla. “This is just code for vaccines cause autism,” she said.Bandim has put out a rebuttal of Stand Up for Science’s criticisms, arguing its work has uncovered a number of vaccine side effects, both positive and negative, which need to be taken into account in public health. However, Congressional Democrats took up the Stand Up for Science cause, and in February, Guinea-Bissau said it had permanently halted the study. WatchdogBut for Delawalla, this is not the end of the fight. Kennedy has made a number of health claims that scientists think lack evidence, such as the idea that seed oils cause inflammation, for example. Delawalla worries that more studies could be launched in poorer countries to fish around for evidence to support this agenda. Stand Up for Science is talking to African science organisations to create a kind of “watchdog” to scrutinise any further trials. “Outsourcing the investigation to some of the most vulnerable children in the world who are desperate [. . .] is fundamentally wrong,” she said.
Busy Baby, which became one of the faces of tariff woes, receives $50K tax refund
Oronoco-based importer Beth Benike said the money helps, but the tariffs caused long-term damage to the company.
Schultz: Outside money is reshaping Minnesota politics ― and pushing it more left
Recent mailers that went out in support of Cedrick Frazier featured a New York return address ― the address of the national Working Families Party, an organization that has received large donations from billionaire George Soros’ Democracy PAC, Jim Schultz writes.
Tax money would make Mamdani's food discounts 'viable'
The city is looking to contract with a private operator willing to run multiple stores.
Science|Business summer reads of 2026
As most people in the European research and innovation policy bubble are going on a well-deserved summer break, we have come up with a list of our favourite books, podcasts and essays from the past year that ask deeper questions about science, technology and politics.BooksPasteur’s Quadrant: Basic Science and Technological Innovation, by Donald StokesIf you haven’t read Pasteur’s Quadrant yet, now is the time. In the EU and elsewhere, we’re living through a period of dwindling faith that curiosity-driven research automatically leads to economic growth and technological progress. Pasteur’s Quadrant, published in 1997 by the Princeton academic Donald Stokes, is the most influential critique of the standard “linear model” of R&D: the idea that new discoveries made in ivory-tower labs get neatly passed on for commercialisation by start-ups. In reality, Stokes argues, practical applications often inspire more theorical lines of inquiry. Of course, we have long known that things are more complex than the linear model, but even today, it’s still often assumed in Brussels discourse. The book is a useful corrective, and is being used now to argue for new types of scientific institutions. David MatthewsThe Weaponization of Expertise: How Elites Fuel Populism, by Jacob Hale Russel and Dennis PattersonAre society’s problems solvable by technical expertise alone? “If only the benighted would listen,” say Jacob Hale Russel and Dennis Patterson, two professors at Rutgers Law School who got frustrated with how scientists and politicians handled public health communication during the Covid-19 pandemic. In the book, they argue that clichéd mantras about scientific evidence and expertise perpetrated by academics, journalists and politicians have harmed public trust in the very institutions they were trying to defend. Paradoxically, slogans such as “we believe in science,” “follow the science” and “defer to the experts” can fuel mistrust in science, experts and democratic institutions. The authors criticise “condescension” and “technocratic paternalism” in the public discourse and make the case for a more nuanced approach to scientific and expert policy advice that rests on humility, doubt, scepticism and open dialogue. “Most complex social questions in fact revolve around values, not the recitation of unambiguous facts,” they say. Florin ZubascuBreakneck: China's Quest to Engineer the Future, by Dan WangIn this book, Dan Wang compares the structural differences between the US and Chinese industrial policies, but raises a very timely question for innovation policy wonks: how can advanced manufacturing know-how contribute to technology-intensive economic growth? Wang says technology has three components: the tools, the blueprints and patents, and the process knowledge. The third component represents the “proficiency gained from practical experience, which isn’t easily communicated and requires years of implementation.” According to Wang, rather than seeing tools and blueprints as the ultimate ends of technological progress, policymakers should see them as milestones in the training of better scientists and manufacturers. Over the past decades, China has amassed “process knowledge” because capital flowed to complex fabrication facilities, while investors in the West have parked their money in capital-light businesses such as digital platforms or chip companies that focus on design. As it turns out, thanks to its oversized focus on manufacturing, China has gained remarkable advantages in the global technology race. Florin ZubascuBaltic: The Future of Europe, by Oliver MoodyWhat can Europe learn from the nine countries surrounding the Baltic Sea? Alongside the familiar stories about Estonia's digital transformation, the book examines how the region has used technology, resilience, education, governance and long-term thinking to respond to geopolitical, economic and security challenges. Innovation policy wonks might find fresh perspectives on how innovation can strengthen defence, societal resilience and Europe's capacity to adapt in an uncertain world. Whether or not you agree with all of Oliver Moody's conclusions, the book is a useful guide to a region that is increasingly shaping European debates on security, competitiveness and technology. Goda NaujokaityteThe Invention of Nature, by Andrea Wulf This book chronicles the wild and adventurous life of natural science pioneer Alexander von Humboldt who at some point in the 19th century seems to have been just about the most famous person in the world. Through scientific expeditions to the Andes Mountains and to the depths of Siberia, von Humboldt contributed a host of discoveries and concepts. During his life he met and formed relationships with historical figures as different as Johann Wolfgang von Goethe, Simon Bolivar, Thomas Jefferson, Napoleon Bonaparte and Charles Darwin. He is also claimed to be the person in the world with most things named after him, a list that includes an ocean current, a penguin and a region of the Moon. Still venerated in Germany, with numerous scientific institutions named after him, von Humboldt has slipped out of public consciousness in most of the rest of the world. For anyone not familiar with him, this book does a good job of describing his fascinating life. Ole EllekrogCareless People, by Sarah Wynn-WilliamsYou may have heard this referred to as the book Meta doesn’t want you to read. The 2025 memoir from Sarah Wynn-Williams, former director of global public policy at Meta, then just called Facebook, includes explosive claims about everything from a toxic workplace culture to how the company worked with advertisers to target vulnerable teens, and the lengths it was prepared to go to in order to break into China. It’s a fascinating insight into how and why the tech company gradually shifted its approach to policy, whether in the US, Europe or Asia. Meta has denied the allegations in the book, and last year won an emergency ruling to prevent Wynn-Williams from promoting it. In response, the author is now suing her former employer. If that doesn’t make you want to read it. Martin GreenacrePodcastsThe Europeans: Europe’s anti-ElonThis podcast is a great choice for a light-hearted dose of European policy and culture news. Most of it has little to do with research, innovation and technology, but this particular podcast features an interview with Mastadon’s founder Eugen Rochko. He talks about his experience running an open-source, federated, European-made social media platform, and leaving it all behind. The conversation, which starts 14 minutes in, gently encourages us to reflect on what kind of technology we, as Europeans, want to make. Goda NaujokaityteSolarpunk and how we escape dystopiaNew technologies are very often taken from science fiction. Alberto Santos-Dumont, inventor the airship, was inspired as a child by the adventure stories of Jules Verne. OpenAI’s attempt to build a personal assistant with the voice of Scarlett Johansson was lifted from the 2013 film Her, completely ignoring the movie’s cautionary message. So if we want better tech, we need to imagine it first. Unfortunately, the state of current sci-fi is relentlessly dystopian, giving inventors precious few ideas or hope. However, a new genre, Solarpunk, which envisages a technologically advanced but ecologically harmonious future, is now taking off. The actual tech the genre imagines, such as permaculture, renewable energy or community repair workshops, while nice, isn’t all that inspiring or ambitious. But it’s a first step towards rescuing sci-fi from its pessimistic Blade Runner rut. David MatthewsEveryday AbundanceLaunched in June, Everyday Abundance is a podcast that tells the stories of the inventions we now take so for granted that we barely given them a second thought. For example, the washing machine, which liberated women from a lifetime “bent over washtubs and washboards.” Or modern dentistry, which ended the reality that “tooth pain was simply part of human life.” Historians of technology, Virginia Postrel and Charles C Mann are very much on the optimistic end of the spectrum when it comes to the capacity of invention to improve human life. Here, they set out their case: if it wasn’t for progress, you might be hunched over a washtub with toothache rather than reading these words. David Matthews‘We will not know what we lost’: Conservation fallout a year after USAID shutdownSince his return to the White House, Donald Trump has been on a mission to undermine science. He slashed jobs at federal agencies, terminated grants in some research areas, took unprecedented control over university affairs and, within hours of his inauguration, suspended the US Agency for International Development. While its initial focus was to administer health and food aid around the world, it had since expanded to conservation projects. The result? Some of these projects were stopped abruptly. In this Mongabay podcast, environmental reporter Michelle Nijhuis tells the story of the EcoGuard conservation programme in Liberia, whose local patrols had helped protect rainforests, monitor endangered wildlife and track illegal threats. From one day to the next, these were left without salaries. Luckily, she notes, the initiative was able to get emergency funding from international NGOs, but its future remains “incredibly uncertain.” Juliette PortalaEssaysThe Mars Delusion, by Henry WismayerWhy is humankind so fixated on establishing a colony on Mars? asks London-based writer Henry Wismayer. From space evangelists promoting Martian settlement as an insurance policy, to billionaire Jeff Bezos, who said humans should settle on Mars “because it’s cool,” the mission is not running short of advocates. However, in this essay, Wismayer reminds us that some critics expect any future Mars pioneer to end up “irradiated, sick, mad and dead.” Scientists have already looked into the possible effects of prolonged exposure to Martian gravity, and it’s not pretty: muscle shrinking, bones weakening, changes to the central nervous system and other biological modifications to make us all reconsider the journey. “Some researchers have forecast that the future settler, after generations of evolutionary conditioning, will look less like an Übermensch and more like ET,” Wismayer writes. Juliette Portala
Media Mogul Tom Rogers sees trouble in Disney's ad business
Tom Rogers, Versant Media senior advisor, joins 'Fast Money' to talk Disney earnings and AI usage in Hollywood.
Investors are having doubts about Elon Musk’s grandiose ambitions
SpaceX is spending gobs of money to refashion itself as an AI company
Michigan Supreme Court asked to block 'money out of politics' proposal
A group fighting a petition initiative that would bar state-regulated corporations from political spending has asked the high court to block it
Whoopi Goldberg suggests she’d exit ‘The View’ if she was richer
Whoopi Goldberg has suggested that she’d leave ‘The View’ if she had more money: ‘Don’t know if I’d still be doing the show,’ she told actress Keke Palmer in a new podcast interview.
Progressive Abdul El-Sayed wins Michigan's Democratic primary for Senate
El-Sayed, an epidemiologist, backs Medicare for all and decries corporate money in politics. He beat Rep. Haley Stevens, whose supporters said she would have had a better chance in the fall.
Preview: Bull Mania 2026 in Holdenville
The Holdenville Roundup Club’s Bull Mania 2026 event is set for Saturday night at 8 p.m., featuring cowboys competing for $40,000 in prize money as part of the LJ Jenkins Bull Riding Tour at 971 Fairgrounds Road in Holdenville, Oklahoma. Admission is $15 for adults and $5 for kids 10 and under, followed by a dance.
Paid Leave is helping workers — and businesses like mine
For small businesses like mine, the Paid Leave program saves me money while providing a safety net that my employees deserve.
‘I did not steal’: Jacksonville businesses accuse influencer of taking money without delivering. He denies it
A social media influencer accused by Jacksonville-area businesses of taking money for food reviews and failing to deliver what they expected is pushing back against the allegations, saying he never stole from anyone and that some of the claims against him are false.
MrBeast Sales Slow, Angel Stock Falls, MUBI and Neon Look for Hits, and Will an NBA Franchise Set a Sales Record?
(Welcome to the Entertainment Strategy Guy, a newsletter on the entertainment industry and business strategy. I write a weekly Streaming Ratings Report and a bi-weekly strategy column, along with occasional deep dives into other topics, like today’s article. Please subscribe.) You probably remember egg prices spiking a few years ago. This led to a lot of debate between the pro-market/pro-competition/antitrust/Neo-Brandesian crowd and the center/center-right/center-left/abundance/libertarian crowd over the cause, whether it was the avian flu outbreak or whether industry consolidation led to price fixing, using avian flu as a convenient cover. Basel Musharbash wrote a whole investigation at BIG looking at it. Well, two years later, we have our answer: it was price fixing. The Justice Department found proof, via emails, of price fixing. Indeed, just the threat of an investigation brought prices down two years ago: I bring this up because at least half a dozen of my favorite political writers and pundits, who were skeptical about price fixing at the time, haven’t written any mea culpas on this issue. It’s really dispiriting and makes it much, much harder to trust their work on other issues. If you take a hard stand on an issue, then you get it wrong, you need to explain how and why you got it wrong. Or update your priors. This is how epistemological bubbles are formed! All of which is to say, it’s time for another installment of “What I Got Right, What I Got Wrong”. Last issue, I mostly focused on the “wrong” side of the equation, so today’s is a bit more balanced, but with one big mea culpa (though I still stand by my original concerns). Let’s dive right in! Subscribe CORRECTION: UFC Didn’t Release Subscriber Data (But Seems to Have Bragged About It Internally) In my analysis of the viewership of UFC Freedom 250, I wrote... “Paramount has also released datecdotes bragging about their subscriber numbers. Earlier this year, they claimed that the first UFC fight on Paramount+ brought in 1 million subscribers.” Well, that datecdote did not come from a PR rep, but from great reporting from James Faris at Business Insider. The actual quote was this: “Paramount’s flagship streaming service generated about a million new subscribers on the day of its first-ever UFC event, Paramount product chief Dane Glasgow told employees in a town hall on Tuesday morning, three staffers who attended the meeting told Business Insider.“ This wasn’t the biggest goof in the world; even Faris emphasized to me that this is more a “clarification” than a correction. Still, it sounds like, internally, the folks at Paramount were very happy about this result—and I’m guessing they were happy with this news getting out—even though the gains didn’t last through the quarter, dropping to 700K adds. RIGHT: MrBeast’s Struggles Continue... I’m very skeptical about MrBeast’s burgeoning media “empire” and, in particular, its $5 billion valuation, as I wrote earlier this year and last year. Sure enough, according to Business Insider, regarding its “booming” consumer products division_:_ “US sales volume grew 13% year-over-year in 2025, following a 33% leap the previous year, according to a presentation deck dated May 2026....A February 2025 investor deck viewed by Business Insider showed Feastables’ net revenue more than doubled in 2024 from 2023, to $215 million, and was forecast to grow 74% in 2025, to $375 million.” [Emphasis mine.] If you told investors that you projected 74% growth but delivered 13%,1 that’s not ideal. But it’s not just MrBeast. Logan Paul and KSI’s Prime had sales drop in half for their energy drinks. It’s one thing to build a successful entertainment company and an entirely different thing to succeed in the heavily-consolidated-but-also-very-competitive consumer packaged goods space! CPGs are dominated by a few firms with very wide moats compared to YouTube, which has few barriers to entry. These businesses require different skill sets and have completely different business environments. WRONG: Does the NBA Have an $8 Billion Bidder? Almost as soon as I published my article about the NBA’s finances, casting skepticism on NBA expansion, I saw this Front Office Sports headline: One group “claims to have already raised $8 billion” for the Vegas expansion team. I mean, wow. That’s just $2 billion less than what the Los Angeles Lakers were valued at when they were sold just last year. And they’re arguably the most popular team in the NBA. (Side note: the new owner is now under an investigation for fraud in how he went about financing the Lakers and the Dodgers purchases.) So much for the “dried up” language I used in that article. (This is why I usually stick to my “Entertainment Nuance Guy” tone in articles...) I went off old information—from April, when I read/heard about the NBA downplaying expansion efforts—instead of doing a quick double-check for new news. That said...if you read the article, the market for Seattle is “slow”, with just one reported bidder. So I wasn’t entirely off. This goof has annoyed me since I first published it, mainly because it undercut that article’s real point, which I stand by: NBA franchises are really overvalued right now. Now, I get why NBA teams are overvalued. When it comes to owning sports teams, it’s basically never wrong to assume that some rich person somewhere will care more about owning a team (or just being part of a group since they’re so expensive) than the actual financials. There are only so many teams to own, and opportunities to buy in preferred markets don’t come along very often. This explains why the teams sell for such high multiples (usually above a 10 to 12.5 revenue multiple, which is very high). You only need one person to overpay! Beyond the ultra-wealthy luxury good explanation, I worry NBA teams are becoming speculative assets. More and more private equity investors are buying into NBA teams. But the value, in owning a team, comes from selling it later, not any meaningful relationship to revenue or profit growth. In other words, the newer NBA owners are increasingly expecting someone later to buy their inflated asset. That’s not sound economics; that’s the “greater fool” theory at work.2 At some point, actually making money has to matter. Especially since revenue growth is now below the growth of the stock market. (And this matters because the NBA doesn’t have easy levers to pull to drastically lower their costs—half of their revenue has to go to players and then you actually have to run a team, including coaching, training, travel, media expenses, and more—or raise revenues aside from one-off expansions in America and overseas.) I just don’t see how investors make their money back buying NBA teams, except for selling at a higher price later on down the line. But if revenue/profit growth continues to slow, at some point, someone will be left holding the bag. RIGHT: Baseball and Basketball are about equally popular. Related to the above, I wanted to cite two quick pieces of evidence for one of my other theories: that the NBA and MLB are about as popular as each other, but the NBA gets much, much better media coverage. One YouGov survey has that fans prefer basketball to baseball by 52% to 48%, which I’m guessing is within the margin of error for that poll. That’s virtually even, meaning they’re about the same popularity. Over on NBC, a recent Red Sox-Yankees game averaged 4 million viewers, higher than Sunday Night Basketball’s average of 3.4 million on the same network. A Yankees-Dodgers game averaged 3.9 million two weeks ago. Not every game averages this much, but it shows you that baseball isn’t far off from basketball, depending on the matchup. Altogether, the NBA is just slightly more popular than baseball, but NBC is paying MLB a fraction of what they pay the NBA, a point I’ve made before. RIGHT: Angel, MUBI and Neon Updates... I’ve long been skeptical about many of Hollywood’s buzziest startups/smaller indie studios. It’s not that they don’t make great movies—films like Anora and Everything Everywhere All at Once are amazing—or that they’re not (rightfully) pushing the majors to make better films, but...they get a ton of hype, and that hype often doesn’t live up to the reality or difficulty in scaling up. Starting with MUBI, well, The Wall Street Journal wrote a feature on MUBI’s struggles last April, best summarized by the subheader “After Sequoia valued Mubi at $1 billion, a left-wing revolt sent the indie film company into a tailspin”. MUBI lost $7.3 million on $200 million in revenue in Q4 2025, but reportedly hit a record 1.7 million subscribers at the end of Q1. As for Neon, Department M purchased a “significant stake” in the company earlier this year. How much is that “stake” worth? According to Deadline, “No financial figures for the Neon-Department M deal were disclosed.” So...that’s not great! If it was a big valuation, we’d hear about. Also, I found this curious: “Both Neon and Department M already have separate partnerships with Qatar. The Qatar Film Committee has a slate deal in place with the former, and a biopic production pact with the latter.” Color me skeptical about much Middle Eastern investment dollars. See: LIV Golf. Finally, as for Angel (formerly Angel Studios), their stock very, very slightly popped last month after Young Washington ($20 million budget) which made $45 million in the US, but their stock is still way down from its opening. Smaller Updates RIGHT: The WGA should focus on antitrust concerns! I’ve been on this for years. Post-WGA/AMTPT deal in 2023, I wrote an article for the Ankler calling on the WGA to focus and organize against industry consolidation. Sure enough, the WGA filed a lawsuit against the Paramount-WBD merger, and people are organizing around this issue now. I wish this energy had coalesced earlier (specifically to lobby Washington much earlier), but better late than never! WRONG: Actually, the chip shortage might be due to market manipulation. In my last “Long Reads for the Long Summer” article, I shared an article about how LLMs are causing memory chip prices to spike, which will make all electronics more expensive. Well, turns out, three RAM manufacturers control 90% of the market, and now a private lawsuit accuses them of price-fixing. So yeah. WRONG/UPDATE: The Odyssey will hold! Two weeks ago, I wrote, “As of this moment, we haven’t had a super-blockbuster, though The Odyssey, Spider-Man: Brand New Day and Avengers: Doomsday could all cross the $500 million mark. (At this point, The Odyssey would need a very strong hold to get there.)” Well, it’s safe to say it’s going to have that hold! It only dropped 30% in weekend two and IMAX screenings are sold out all month. Spider-Man: Brand New Day is also off to a great start. RIGHT: People are rushing to get shows out yearly. I’ve long been bullish on yearly, weekly-released shows, and Leslie Goldberg at The Ankler wrote about how many people in town are now listening. WRONG: Mark Carney reverses Canada’s stance on homegrown production. After writing about Canada installing domestic production quotas, Canada has backed off. WRONG: I don’t trust Spider-Man: Brand New Day’s online “views”. When I originally wrote about the latest Spider-Man film’s record-breaking trailer, I thought this was just YouTube views, but after watching this Corridor Crew video and doing more research, well, it’s all social views of the trailer globally. Really? That stat includes TikTok, Reels and YouTube Shorts views. Basically, I don’t trust it anymore. (This film will probably set record, but I trust the pre-sales data more.) RIGHT: Celebrity Production companies are still struggling. I’ve written about this for years, but the company that I didn’t track was Kevin Hart’s HartBeat, which was valued at $650 million but is struggling now and might just end soon, especially after Kevin Hart pulled his endorsement deals. And Bad Robot is moving to NYC. CORRECTION: SpongeBob is a “second run” title. In my 2025 recap article, I had _SpongeBob SquarePants_labelled as a “library” title, when it is still a “second run” show, with new episodes still coming out on Nickelodeon. CORRECTION: In my last “What I Got Right, What I Got Wrong” update, I offered a correction from Doug Creutz and misspelled TD Cowen. Thanks, Grammarly! 1 Though he could have increased prices to make up for the gap, he couldn’t have increased them that much. 2 There’s a theory, which I think that Daryl Morey created and Bill Simmons popularized, that, to be successful building your team, you only need a handful of bad GMs in the league to take advantage of. To be clear, Daryl Morey’s theory was also for signing bad contracts, that you could always get out of bad contracts. Basically, there’s always someone who will make a bad trade. It’s not the same exact thing, but similar enough to the Greater Fool Theory that I really like it.
Business News, Personal Finance and Money News
Find the latest business news on Wall Street, jobs and the economy, the housing market, personal finance and money investments and much more on ABC News
Analysis
A lot of money is being spent in this year’s primaries. It’s becoming a huge focus of the races.
Early TAVR for patients with asymptomatic severe AS may save money in the long run
Treating asymptomatic patients with TAVR may cost more at first, but it appears to be a wise financial decision as time goes on.
Capital One says money laundering concerns led to closure of Trump Org accounts, not politics
Trump’s claims that various banks closed accounts linked to his family over political reasons after Jan. 6 just took a fresh turn.
Trump bank accounts were closed due to concerns over possible money laundering, Capital One says
The court filing is tied to a lawsuit filed against Capital One by one of Trump’s financial holding companies shortly after he was sworn into office a second time.
The Lumbee Tribe Wants Better Health Care. It May Be On Its Own.
Researchers and health care providers say money from the Indian Health Service won't be enough to meet the tribe's needs.
MLB Predictions and Moneyline Picks for Monday, August 3
Moneyline leans and insights for Monday, August 3 from Colby Marchio. Check out the teams he's backing this evening!
Marmots got money troubles: UCLA scientists turn to OnlyFans
A UCLA marmot lab has opened an OnlyFans account called OnlyMarms to raise funding for its research. So far, it's raised about $4,000.
Blanche scraps Trump’s $1.8 billion anti-weaponization fund
President Trump’s nominee for attorney general, Todd Blanche, said he is formally rescinding the controversial fund. It was created as part of an agreement to settle a lawsuit from Trump against the IRS and would have offered taxpayer money to people who claimed they were victims of weaponization by the federal government.
What Are Companies Getting for All That A.I. Spending?
A new field of “tokenomics” has emerged to measure the return on all the money companies are pouring into artificial intelligence.
Razer Blade 18 Review: Biggest (but Not Heaviest), Baddest Gaming Laptop Money Can Buy
And it will take a lot of money to buy.
Big Money In Hawaiʻi Politics — The Carpenters Union Is Crushing Everyone
Other political action committees are spending hundreds of thousands of dollars on candidates, too, but their financial efforts fall far short of the Carpenters Union.
Man turns side hustle into $4 million video game resale business
Caleb Ashton said he used $500 worth of birthday and Christmas money to launch QuickFlips, a video game resale platform that now makes millions.
The Ultra-Rich Are Moving to Miami, and Want Their Money Managers There, Too
Tax incentives, among other benefits, have drawn the ultrawealthy to the city. And they need space for the firms that manage their money.
U.S. Restores Some Vaccine and Health Aid to Unicef, Gavi and World Food Programme
The amount is still far below what the U.S. spent previously on humanitarian and health aid, but resumes the flow of money for key efforts to fight malnutrition and disease.
Cowboys’ George Pickens Eyeing Record-Breaking WR Contracts
Cowboys star George Pickens is on a one-year franchise tag contract. He's been paying attention to the big money other WRs are getting. The post Cowboys’ George Pickens Eyeing Record-Breaking WR Contracts appeared first on HEAVY.
Editorial: Pennsylvania health insurance rates need triage
The cost of staying healthy is climbing. The cost of getting sick is even worse. Prescription drug costs are up. So is the amount of money people spend in urgent care — and that’s affordable compared with an emergency room visit. Testing, diagnostics, office visits, the little extras you don’t